HIV

Sort options

Introduction to Participatory Approaches in Public Health (Coursera)

Nov 1st 2021
Introduction to Participatory Approaches in Public Health (Coursera)
Course Auditing
Categories
Effort
Languages
This course will introduce you to participatory approaches to public health. You will learn about the history of participatory health research and why it is essential to solving contemporary public health challenges. The course will help you to understand the social and cultural context of public health, before introducing [...]
10
Average: 10 ( 4 votes )

Global Disease Masterclass: Communicable Diseases Epidemiology, Intervention and Prevention (Coursera)

This course is all about infectious diseases. We’ve selected four disease areas — HIV, Malaria, Emerging Infectious Diseases (Ebola and Zika), and TB — and we will go through each in turn. We’ve selected these diseases because they span a range of different types of disease and allow us [...]
0
No votes yet

PrEParing: PrEP for Providers and Patients (Coursera)

Pre-Exposure Prophylaxis (PrEP) using the antiretroviral medication emtricitibine/tenofovir approved in countries around the world is a highly effective means of reducing transmission of HIV through sexual encounters and needle sharing. This Johns Hopkins University course PrEPares you with essential information, concepts and practical advice regarding PrEP from leaders in [...]
0
No votes yet

International Women's Health and Human Rights (Coursera)

This course focuses on women’s health and human rights issues from infancy through old age, including information about positive interventions relating to those issues. Learners are encouraged to interact with each other through interactive discussions. It is important to us that this course be available to all learners. [...]
8
Average: 8 ( 3 votes )

AIDS: Fear and Hope (Coursera)

The basic biology of the virus, HIV, and the disease it causes, AIDS. The economic, social and political factors that determine who gets sick and who remains healthy, who lives and who dies. The progress of scientific research and medical treatments. The reasons for hope; the reasons for fear.
6
Average: 6 ( 4 votes )

HIV in Africa: Meeting the Challenge (AME)

Diagnostics remains at the cornerstone of universal efforts to end the HIV epidemic, with an extremely rich pipeline of tools and convenience of point of care testing available nowadays. Learn about major concerns in selecting a suitable assay, and how to balance optimally between improved patient outcomes and cost-effectiveness. [...]
0
No votes yet

Identifying and Caring for Multiclass Resistant Patients (AME)

This Online Education Activity is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 1 European CME credit (ECMEC®). Welcome to the Identifying and Caring for Multiclass Resistant Patients edition of the Online Meeting Highlights. Here you will learn more about how to define multiclass HIV [...]
0
No votes yet

Update on INSTIs (AME)

This Online Education Activity is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 1 European CME credit (ECMEC®). Welcome to the Update on INSTIs edition of the Online Meeting Highlights. Here you will learn about HIV integrase strand transfer inhibitors (INSTI), compiling for you data [...]
0
No votes yet

HIV Care for Underrepresented Populations (AME)

This Online Education Activity is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 1 European CME credit (ECMEC®). Welcome to the Care for Underrepresented Populations edition of the Online Meeting Highlights. Here you will learn about how to solve this fundamental HIV puzzle step by [...]
0
No votes yet

Update on HIV Treatment Options (AME)

This Online Education Activity is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for 1 European CME credit (ECMEC®). Welcome to the Update on HIV Treatment Options edition of the Online Meeting Highlights. Here you will learn about the safety profiles of Integrase inhibitors-based regimens, potential [...]
0
No votes yet